Navigation Links
Advanced Imaging Technologies to Limit Breast and GI Biopsy Procedures
Date:11/12/2008

Growth will continue to occur through 2013, according to Millennium Research Group

WALTHAM, Mass., Nov. 12 /PRNewswire/ -- According to Millennium Research Group's (MRG's) US Markets for Biopsy Devices 2009 report, the popularity of advanced imaging technologies will restrict the number of gastrointestinal (GI) and breast biopsy procedures performed through 2013.

The availability of endoscopes with microscopic capabilities for visualizing tissue at the cellular level has decreased the requirement for a biopsy in endoscopic GI procedures. PENTAX's Confocal Endomicroscope, for example, enables physicians to examine inner structures at extreme magnifications, in some cases allowing for diagnosis without the need for a biopsy. Should additional competitors enter the endomicroscopy market, unit growth for GI biopsy forceps will slow.

"Likewise, breast biopsy procedures will be affected by advanced imaging technologies," says Sarah Leonard, Analyst at MRG. "Improvements in breast imaging technology are leading to more accurate evaluations of suspected breast cancers, potentially reducing the need for breast biopsies. In particular, breast MRI, breast-specific gamma imaging, and positron emission mammography provide information that can help determine whether a suspicious lesion is benign or malignant, boosting the appeal of diagnostic breast imaging and slowing growth in the number of breast biopsies being performed. Nevertheless, physician fear of malpractice lawsuits and limited reimbursement for advanced imaging will prevent US breast and GI biopsy procedure volumes from declining in the next five years."

MRG's US Markets for Biopsy Devices 2009 report provides coverage of key industry competitors including Angiotech, Boston Scientific, Cardinal Health, ConMed, Cook Medical, C.R. Bard, Ethicon Endo-Surgery, Hologic, Olympus, PENTAX, SenoRx, and more.

About Millennium Research Group

Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc. company (http://www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through published reports, ongoing Marketrack(TM) projects, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Amy Krohn

Millennium Research Group

416-364-7776 x101

akrohn@mrg.net

Elizabeth Marshall

Decision Resources Inc.

781-296-2563

emarshall@dresources.com


'/>"/>
SOURCE Millennium Research Group
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Unilens Launches New C-VUE(R) Advanced(TM) Custom Toric Lens
2. Philips Introduces New, Advanced Light Therapy Device to Offer Quick Relief from Winter Blues
3. Many Breast Cancer Patients Are Not Receiving Most Advanced Breast Conserving Surgical Techniques, New Study Finds
4. Top Indian Cancer Hospital to Introduce Advanced Radiosurgery Treatments With Novalis Tx from Varian Medical Systems and BrainLAB
5. Advanced Health Care Options for People With Diabetes
6. Doctors Test Advanced Tool for Treating Prostate Cancer
7. Relations PR & Marketing Named Agency of Record for Advanced Ultrasound Services
8. Glycotex Finalizes Collaboration Agreement with Advanced Medical Solutions
9. Advanced Circulatory Systems Receives $1.5 Million From NIH for Study of Cardiac Arrest Resuscitation Techniques
10. Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region
11. 27 National Nursing Organizations Join Together to Commission a Study of the Impact of Advanced Practice Registered Nurses on Healthcare Quality, Safety, and Effectiveness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
Breaking Medicine Technology: